HK Stock Market Move | JINHAI MED TECH (02225) up more than 15% during trading hours. Jinhai Medical collaborates with Medtronic to launch innovative spine endoscope navigation technology at the Import Expo.

JINHAI MED TECH (02225) rose more than 15% during trading hours, with a 5.04% increase at the time of writing, reaching 1.25 Hong Kong dollars with a trading volume of 12.1974 million Hong Kong dollars. On the news front, the 8th China International Import Expo took place in Shanghai from November 5th to 10th. JINHAI MED TECH previously announced that during the Expo, its subsidiary Jinhai Medical will jointly release the latest research and development of navigational endoscopic spine technology with Medtronic China Orthopedics and Neurosurgery Business Group (Medtronic China). This technology is expected to be applied in spinal surgery and is envisioned to open up a new path for the precision and intelligence development of spine surgery, reducing the learning curve for clinical doctors in endoscopic spine technology, and promoting its more efficient and widespread clinical application in the future. It is reported that Medtronic's main business covers the research, development, manufacturing, distribution, and sales of medical devices and services in the fields of cardiovascular diseases, neuroscience, medical surgery, and diabetes. Medtronic has production bases in Shanghai, Changzhou, and Chengdu, China. Since the first China International Import Expo in 2018, Medtronic has participated for seven consecutive years, showcasing and accelerating the application of its latest Innovative Medical Management technology and products with the Expo's strong influence.